News

Asymptote CellSeal Automated Thawing System

Cook Regentec and Asymptote Introduce the CellSeal Automated Thawing System

Cook Regentec, focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient, and Asymptote Ltd., specialists in cryochain for regenerative medicine, today announced the launch of the CellSeal® Automated Thawing System. The new system, which has been developed as part of a collaboration between the two companies, provides users with thorough control in the thawing of cryogenically frozen cells, a critical step in the delivery of cell and gene therapies. The CellSeal®…

Finesse Solutions Announces CellWorld 2017 Executive Forum

Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, is pleased to announce the dates and topics for CellWorld 2017, a Finesse-sponsored event designed for innovators, visionaries and senior executives in bioprocessing. This invitation-only conference will be held April 25-26, 2017 at the Hilton San Francisco Financial District. It will be a forum for life sciences leaders to discuss the future of biosimilar manufacturing and learn about both disruptive technologies and best practices for…

BioOutsource_Boston_Lab

Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts. This dedicated bioanalytical laboratory is designed to accommodate the rising demand for the company’s BioOutsource brand specialized assay platforms in North America and facilitate the ongoing expansion of this unique service offering. At the opening ceremony, Reinhardt Vogt, member of SSB’s Executive Committee, welcomed many representatives from the biotech industry and…

enzo_110816-kit

Enzo Life Sciences Launches New PLAQPRO™ Lp-PLA2 Assay to Measure Cardiac Risk

Enzo Life Sciences is proud to introduce our new assay, PLAQPRO™ Lp-PLA2 Assay, measuring the activity of Lp-PLA2 in vitro.  Lp-PLA2 is produced by inflammatory cells and circulates primarily bound to LDL. The oxidization of LDL is an early key event in the pathogenesis of atherosclerosis. Increased levels of Lp-PLA2 have been found in atherosclerotic plaques and rupture lesions. The PLAQPRO™ Lp-PLA2 Assay is a colorimetric readout assay that measures the activity of Lp-PLA2 in serum samples. Our assay represents a cost-efficient alternative to…

enzo_110816

Enzo Life Sciences Launches New Immunoassay to Detect Low Levels of IL-6

Enzo Life Sciences is proud to introduce our newest immunoassay, IL-6 (human), high sensitivity ELISA kit, the most sensitive IL-6 ELISA on the market. Enzo’s new kit is able to detect IL-6 levels down to 0.057 pg/mL. In addition, our kit offers detection in 3 hours, with liquid color-coded reagents that reduce the possibility for error. From forty years of manufacturing, Enzo’s immunoassays offer high precision, accuracy, sensitivity, and specificity. IL-6 is a cytokine critical to the regulation of the…

Microbial Testing Without the Burden: New EZ-Fit™ Filtration Units from MilliporeSigma

MilliporeSigma has expanded its portfolio of EZ-Fit™ filtration units, ready-to-use, disposable filtration devices for bioburden testing. The new EZ-Fit™ filtration units come with a wide range of membrane sizes to suit all applications, and a new patented drain design to accelerate processing of turbid and hard-to-filter matrices. The full portfolio, including the new units, conforms to international standards (USP/EP) and water testing regulations, and can be used for filtration of liquid samples including water, raw materials, in-process samples and final…

CASSS and Biophysics Working Group Aim to Increase Scientific Dialogue About Biologics

CASSS has partnered with the Biophysics Working Group to support its mission to bring together scientists from across public and private sectors to address challenges in biologics research and development. The goals of the Biophysics Working Group are to provide guidance and best practices, support innovation, advance transformative ideas, and generally enhance the overall scientific dialogue through contributions in various publications and CASSS conferences around the world. This group also aligns with CASSS’s purpose to enable a global community of…

Finesse® Solutions Launches SmartVessel™, a Single-Use 3L Bioreactor for Cell Culture and Fermentation

Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of SmartVessel, a single-use 3-liter bioreactor vessel. The SmartVessel features integrated single-use sensors for cell culture applications of mammalian, stem, insect, and plant cells. The SmartVessel also has separate electrochemical sensor ports for fermentation and bio-fuels applications.   All wetted materials of the SmartVessel are USP class VI-compliant, animal derived component-free, latex-free, BPA-free, and phthalate-free. This stirred tank bioreactor allows working volumes ranging…

Lonza and Forty Seven, Inc., Announce Strategic Manufacturing Agreement for Immuno-Oncology Therapeutic Antibody Pipeline

Lonza, a global leader in biological manufacturing, and Forty Seven, Inc., a clinical-stage immuno-oncology company, announced today a strategic manufacturing agreement for the clinical supply of Forty Seven’s therapeutic antibodies. Under the agreement Lonza will manufacture material at its Slough (UK) facility for Forty Seven’s ongoing and future clinical trials. Forty Seven is committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity. Its lead molecule, Hu5F9-G4, is a…

PROVEO Partnership Expands with Addition of Cerbios-Pharma and Oncotec Pharma for the Manufacture of ADCs

CMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika GmbH, a privately-held life-science company with a 95 year history of expertise in research, development and manufacture of biologics for human and animal health, announced the addition of Cerbios-Pharma SA (“Cerbios”) and Oncotec Pharma Produktion GmbH (“Oncotec“) to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of…